Myelodysplastic Syndromes (MDS): A Group of Diseases

Daniel Pollyea, MD, MS Please join us as we speak to Dr. Daniel Pollyea from the University of Colorado School of Medicine.  In this episode, Dr. Pollyea discusses the group of diseases that make up Myelodysplastic Syndromes (MDS) and how their variability leads to different treatments and prognoses, from active monitoring to chemotherapy and/or stem cell transplantation.  He shares his excitement about new treatment advances and is looking forward to an era of innovative targeted treatments for MDS. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode:  Myelodysplastic Syndromes (MDS)Myelodysplastic Syndromes (MDS) BookletsAcute Myeloid Leukemia (AML)Stem Cell TransplantIPSS-R Scoring SystemIPSS-M Scoring SystemClinical Trial Support Center Additional LLS Support Resources:  Information SpecialistsFinancial supportFree telephone/web patient programs Patti Robinson Kaufmann First Connection ProgramFree booklets LLS Public Policy & AdvocacyOnline chats Caregiver support Support groups Free Nutrition Consultations LLS AdvocacySurvivorship Workbook Support for this episode provided by Taiho Oncology. The post Myelodysplastic Syndromes (MDS): A Group of Diseases first appeared on The Bloodline with Blood Cancer United Podcast.